Laura Damme - 14 Dec 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP, Clinical Affairs
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 14 Dec 2022
Net transactions value: -$245,110
Form type: 4
Filing time: 16 Dec 2022, 15:30:20 UTC
Previous filing: 24 Feb 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$228,722	+5,947		$38.46	5,947	14 Dec 2022	Direct
transaction	TMDX	Common Stock	Sale	$371,271	-5,947	-100%	$62.43	0	14 Dec 2022	Direct	F1
transaction	TMDX	Common Stock	Options Exercise	$9,615	+250		$38.46	250	15 Dec 2022	Direct
transaction	TMDX	Common Stock	Sale	$15,005	-250	-100%	$60.02	0	15 Dec 2022	Direct	F2
transaction	TMDX	Common Stock	Options Exercise	$182,300	+4,740		$38.46	4,740	15 Dec 2022	Direct
transaction	TMDX	Common Stock	Sale	$279,470	-4,740	-100%	$58.96	0	15 Dec 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-5,947	-24%	$0.000000	19,053	14 Dec 2022	Common Stock	5,947	$38.46	Direct	F4
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-250	-1.3%	$0.000000	18,803	15 Dec 2022	Common Stock	250	$38.46	Direct	F4
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-4,740	-25%	$0.000000	14,063	15 Dec 2022	Common Stock	4,740	$38.46	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4	The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.